ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 1 filers reported holding ACASTI PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $115 | -8.0% | 250 | 0.0% | 0.00% | – |
| Q4 2022 | $125 | -87.5% | 250 | -87.5% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 2,000 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -80.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | 0.0% | 2,000 | -60.0% | 0.00% | – |
| Q1 2018 | $5,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 236,559 | $414,000 | 0.03% |
| INTACT INVESTMENT MANAGEMENT INC. | 89,490 | $206,000 | 0.01% |
| Virtu KCG Holdings LLC | 29,187 | $52,000 | 0.00% |
| TORONTO DOMINION BANK | 25 | $0 | 0.00% |
| BANK OF MONTREAL /CAN/ | 177,389 | $317,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 600 | $1,000 | 0.00% |
| Renaissance Technologies | 35,400 | $63,000 | 0.00% |
| ROYAL BANK OF CANADA | 75 | $0 | 0.00% |
| UBS Group AG | 1,061 | $2,000 | 0.00% |